The Diabetes Prevention Program randomized 3,234 adults with overweight or obesity and impaired glucose tolerance to metformin, placebo, or intensive lifestyle
This article traces that evolution, explains exactly how these drugs work inside the pancreas, gut, and brain, and offers a clear rundown of every GLP-1 option on the marketand in the pipelineso you can make informed, evidence-based decisions for metabolic health
A: No, Retatrutide is a weekly medication
Obesity and autoimmune disease are each associated with a higher risk of cardiovascular and blood clot events
Focusing on gut health aids that might alleviate gastrointestinal side effects and nutritional supplements that help offset deficiencies linked to reduced food intake
HSA and FSA accounts are eligible for reimbursement, and pricing remains flat regardless of dose escalation